<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35562145</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">0974-5130</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>Supplement</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Indian journal of pathology &amp; microbiology</Title><ISOAbbreviation>Indian J Pathol Microbiol</ISOAbbreviation></Journal><ArticleTitle>Neuropathology of COVID-19.</ArticleTitle><Pagination><StartPage>S146</StartPage><EndPage>S152</EndPage><MedlinePgn>S146-S152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/ijpm.ijpm_1103_21</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has placed global health care systems under unprecedented strain but has, at the same time, provided a unique opportunity for pathologists to turn autopsy findings into directly actionable insights into patient care. The current data on the neuropathology of COVID-19 remains preliminary and is limited by the lack of suitable controls, but certain tentative conclusions can be drawn. SARS-CoV-2 can infect multiple cell types in the central nervous system and does so in a subset of patients, although the clinical significance of direct infections remains in the central nervous system (CNS) and the peripheral nervous system (PNS) infections remains unclear. The best-described neuropathological manifestations of COVID-19 in the brain are variable patterns of neuroinflammation and vascular injury, although again, it remains unclear to what degree these findings are specifically due to COVID-19. There is also intriguing preliminary data to suggest a complex relationship between COVID-19 and neurodegeneration, with certain alleles that increase AD risk also increasing the risk of severe COVID-19, and conversely, the possibility that COVID-19 may increase the risk of neurodegenerative disease. The neuropathology of so-called "long-COVID" and the potential effects of COVID-19, or critical illness in general, on neurodegenerative disease remains unclear. There is thus an urgent need for long-term cohort studies of COVID-19 survivors, including brain donation, particularly in elderly patients, with careful recruitment of controls with similar non-COVID inflammatory illnesses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Li-Chun</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Iowa Neuroscience Institute; Departments of Neuroscience and Pharmacology, Iowa City, IA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollis</LastName><ForeName>Bailey</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Human Physiology, Iowa City, IA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hefti</LastName><ForeName>Marco M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Iowa Neuroscience Institute; Pathology, Iowa City, IA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Pathol Microbiol</MedlineTA><NlmUniqueID>7605904</NlmUniqueID><ISSNLinking>0377-4929</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autopsy</Keyword><Keyword MajorTopicYN="N">Covid 19</Keyword><Keyword MajorTopicYN="N">neurologic manifestation</Keyword></KeywordList><CoiStatement>None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>21</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35562145</ArticleId><ArticleId IdType="doi">10.4103/ijpm.ijpm_1103_21</ArticleId><ArticleId IdType="pii">IndianJPatholMicrobiol_2022_65_5_146_345043</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>